Enveric Biosciences Inc [NASDAQ: ENVB] gained 74.49% or 4.41 points to close at $10.33 with a heavy trading volume of 34856143 shares.
It opened the trading session at $11.6, the shares rose to $13.25 and dropped to $8.6, the range by which the price of stock traded the whole day. The daily chart for ENVB points out that the company has recorded -30.01% loss over the past six months.
If we look at the average trading volume of 125.50K shares, ENVB reached to a volume of 34856143 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Enveric Biosciences Inc [ENVB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ENVB shares is $1800.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ENVB stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 1.55, with the Price to Cash per share for the same quarter was set at 6.31.
Trading performance analysis for ENVB stock
Enveric Biosciences Inc [ENVB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 75.08. With this latest performance, ENVB shares gained by 78.72% in over the last four-week period, additionally sinking by -30.01% over the last 6 months – not to mention a drop of -83.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ENVB stock in for the last two-week period is set at 72.89, with the RSI for the last a single of trading hit 1.40, and the three-weeks RSI is set at 1.07 for Enveric Biosciences Inc [ENVB]. The present Moving Average for the last 50 days of trading for this stock 6.99, while it was recorded at 7.04 for the last single week of trading, and 13.30 for the last 200 days.
Enveric Biosciences Inc (ENVB) Capital Structure & Debt Analysis
According to recent financial data for Enveric Biosciences Inc. ( ENVB), the Return on Equity (ROE) stands at -262.78%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -212.68%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Enveric Biosciences Inc’s Return on Invested Capital (ROIC) is -325.39%, showcasing its effectiveness in deploying capital for earnings.
Enveric Biosciences Inc (ENVB) Efficiency & Liquidity Metrics
Based on Enveric Biosciences Inc’s (ENVB) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Enveric Biosciences Inc (ENVB) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Enveric Biosciences Inc. (ENVB) effectively leverages its workforce, generating an average of -$2250000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 4.56% and a Quick Ratio of 4.56%, indicating strong ability to cover short-term liabilities.
An analysis of Institutional ownership at Enveric Biosciences Inc [ENVB]
There are presently around $10.51%, or 11.12%% of ENVB stock, in the hands of institutional investors. The top three institutional holders of ENVB stocks are: ADVISORSHARES INVESTMENTS LLC with ownership of 0.32 million shares, which is approximately 7.9233%. GEODE CAPITAL MANAGEMENT, LLC, holding 44659.0 shares of the stock with an approximate value of $$27688.0 in ENVB stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$27268.0 in ENVB stock with ownership which is approximately 1.0886%.
